CliffBio
small molecule

VOGELXO

TESTOSTERONE

Loss of exclusivityFebruary 2034latest FDA-listed patent expiry
CompanyUPSHER SMITH LABORATORIES LLC

Drug detail

Brand nameVOGELXO
Active ingredientTESTOSTERONE
Strength50MG/5GM PACKET
Dosage formGEL
RouteTRANSDERMAL
ModalitySmall molecule
FDA approvalJune 2014
Marketing statusRX

Listed patents

PatentExpiresType
8785426February 2034product
9662340February 2034product
9295675February 2034product

More from UPSHER SMITH LABORATORIES LLC

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

VOGELXO patent cliff — loss of exclusivity February 2034 | CliffBio